Sertraline and Lapatinib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordLapatinib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both sertraline (an antidepressant) and lapatinib (a cancer medicine) can each affect the timing of your heartbeat. Doctors call this QT prolongation. When two medicines that do this are taken together, the effect can add up, which in rare cases could lead to an irregular heartbeat.
This is a theoretical concern, meaning it is based on how the drugs work rather than lots of real-world cases. The good news is your care team can manage this. Please don't stop or change either medicine on your own. Instead, talk with your doctor or pharmacist so they can decide the safest plan for you.
Effect: Additive risk of QT interval prolongation and potential ventricular arrhythmias (including torsades de pointes) with concurrent sertraline and lapatinib.
Mechanism: Pharmacodynamic (additive), not PK-based. Both agents independently carry QT-prolonging potential; neither is a prodrug relevant here.
Evidence: Theoretical; severity rated major. Onset unspecified.
- Where possible, avoid coadministration per labeling guidance.
- If combined, obtain baseline and follow-up ECGs.
- Monitor and correct electrolytes (K+, Mg2+, Ca2+).
- Review concomitant QT-prolonging drugs; individualize therapy.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
The combined use of sertraline with this medication should be avoided, because doing so may heighten the likelihood of QT prolongation and/or ventricular arrhythmias1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Both medicines can lengthen the QT interval, so the documented guidance is to avoid using them together when possible. Your care team will decide the best approach for you.
- Keep taking both as prescribed unless your doctor tells you otherwise. Do not stop either one on your own.
- Your team may check your heart rhythm (an ECG) and your blood minerals like potassium and magnesium.
- They may consider an alternative to one of the medicines, and any therapy can be adjusted and individualized by your care team.
Tell your doctor or pharmacist about all your medicines, and report fainting, dizziness, or a fluttering heartbeat.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Sertraline and Lapatinib together?
Sertraline and lapatinib can each prolong the QT interval, and combining them may add to that risk, so the guidance is to avoid using them together when possible. Do not change either medicine yourself; talk with your doctor or pharmacist about the safest plan and possible heart monitoring. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Lapatinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sertraline and Lapatinib interaction managed?
Both medicines can lengthen the QT interval, so the documented guidance is to avoid using them together when possible. Your care team will decide the best approach for you. Keep taking both as prescribed unless your doctor tells you otherwise. Do not stop either one on your own. Your team may check your heart rhythm (an ECG) and your blood minerals like potassium and magnesium. They may consider a… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Lapatinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ZOLOFT oral tablets, oral solution, sertraline hydrochloride oral tablets, oral solution. Viatris Specialty LLC (per FDA), Morgantown, WV, 2023. DailyMed
Keep reading about Sertraline
Keep reading about Lapatinib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist